搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
atra
/
财务摘要
Atara Biotherapeutics Inc
ATRA
添加自选
8.560
USD
0.000
0.00%
交易中 09/24, 10:00(美东)
77.13M
总市值
亏损
市盈率 TTM
Atara Biotherapeutics Inc
8.560
0.000
0.00%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
ATRA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Atara Biotherapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
77.13M
股息TTM
0.00
市盈率 TTM
-6.06
每股收益TTM
-1.41
营业收入
120.77M
净利润
-85.40M
净资产收益率
-2.01K%
总资产收益率
-23.08%
Atara Biotherapeutics Inc 财报日历
最新发布
8月 12, 2026
每股收益 / 预测值
-0.32
/-0.32
营业收入 / 预测值
630.00K
/366.67K
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-264.31%
-0.32
-108.34%
-0.29
78.90%
-0.25
89.19%
-0.32
105.04%
0.20
162.54%
3.53
91.52%
-1.19
82.11%
-2.93
77.04%
-3.88
68.60%
-5.65
22.66%
-13.97
--
-16.40
--
-16.92
--
-17.98
--
-18.07
--
-37.83
--
--
--
--
--
--
--
--
营业收入
-96.42%
630.00K
-99.47%
516.00K
-95.13%
1.59M
-91.41%
3.45M
-38.63%
17.57M
258.77%
98.15M
670.30%
32.75M
1779.79%
40.19M
2892.69%
28.64M
2131.40%
27.36M
1823.98%
4.25M
-52.05%
2.14M
-98.14%
957.00K
-83.24%
1.23M
-97.07%
221.00K
-16.96%
4.46M
1232.79%
51.58M
105.91%
7.31M
--
7.55M
--
5.37M
净利润
-302.51%
-4.83M
-110.91%
-4.14M
73.17%
-3.41M
80.36%
-4.30M
112.53%
2.39M
219.71%
38.01M
79.00%
-12.69M
68.61%
-21.91M
73.21%
-19.05M
57.53%
-31.75M
18.94%
-60.45M
17.00%
-69.80M
-485.08%
-71.11M
15.13%
-74.77M
20.11%
-74.57M
0.68%
-84.09M
122.04%
18.47M
-12.47%
-88.11M
-14.81%
-93.35M
-13.88%
-84.66M
利润率
-5749.49%
-767.30%
-2174.26%
-803.29%
-451.02%
-213.54%
-128.60%
-124.62%
120.42%
13.58%
133.37%
38.73%
97.27%
-38.75%
98.33%
-54.51%
99.10%
-66.51%
98.10%
-116.07%
95.79%
-1421.68%
--
-3264.59%
--
-7430.30%
--
-6098.78%
--
-33742.99%
--
-242.66%
--
--
--
--
--
--
--
--
毛利率
-28.05%
69.68%
-4.05%
75.97%
17.95%
93.48%
19.22%
96.67%
15.51%
96.85%
-14.63%
79.18%
208.60%
79.25%
463.44%
81.08%
141.40%
83.84%
12.58%
92.74%
-74.32%
25.68%
--
-22.31%
--
-202.51%
--
82.38%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
81.27%
197.57%
208.03%
207.40%
454.31%
209.65%
410.52%
138.05%
241.60%
109.00%
204.73%
67.33%
64.07%
37.82%
49.54%
27.04%
138.65%
31.91%
108.96%
22.10%
149.98%
23.05%
--
18.08%
--
13.37%
--
10.57%
--
9.22%
--
1.25%
--
--
--
--
--
--
--
--
利润表
营业收入
-96.42%
630.00K
-99.47%
516.00K
-95.13%
1.59M
-91.41%
3.45M
-38.63%
17.57M
258.77%
98.15M
670.30%
32.75M
1779.79%
40.19M
2892.69%
28.64M
2131.40%
27.36M
1823.98%
4.25M
-52.05%
2.14M
-98.14%
957.00K
-83.24%
1.23M
-97.07%
221.00K
-16.96%
4.46M
1232.79%
51.58M
105.91%
7.31M
--
7.55M
--
5.37M
营业利润
-183.75%
-3.95M
-106.39%
-3.37M
89.21%
-1.32M
83.70%
-3.55M
126.41%
4.72M
298.95%
52.72M
77.10%
-12.20M
68.75%
-21.76M
74.97%
-17.88M
64.66%
-26.50M
29.40%
-53.28M
11.58%
-69.61M
-122.25%
-71.41M
15.02%
-74.97M
19.20%
-75.47M
7.17%
-78.73M
61.75%
-32.13M
-12.75%
-88.22M
-14.33%
-93.40M
-13.53%
-84.81M
净利润
-302.51%
-4.83M
-110.91%
-4.14M
73.17%
-3.41M
80.36%
-4.30M
112.53%
2.39M
219.71%
38.01M
79.00%
-12.69M
68.61%
-21.91M
73.21%
-19.05M
57.53%
-31.75M
18.94%
-60.45M
17.00%
-69.80M
-485.08%
-71.11M
15.13%
-74.77M
20.11%
-74.57M
0.68%
-84.09M
122.04%
18.47M
-12.47%
-88.11M
-14.81%
-93.35M
-13.88%
-84.66M
资产负债表
流动资产
-45.38%
13.53M
-55.22%
12.17M
-81.18%
12.21M
-79.93%
18.43M
-60.31%
24.77M
-74.46%
27.18M
-36.30%
64.89M
-22.61%
91.86M
-63.78%
62.41M
-52.52%
106.43M
-65.48%
101.87M
-58.06%
118.70M
-50.34%
172.32M
-28.69%
224.18M
-23.28%
295.08M
-23.40%
283.05M
-11.56%
346.98M
-32.29%
314.39M
-26.50%
384.62M
8.86%
369.50M
流动负债总额
-52.98%
6.85M
-88.21%
5.64M
-88.91%
14.92M
-88.42%
18.06M
-90.18%
14.56M
-73.49%
47.89M
-5.38%
134.57M
97.22%
155.98M
98.88%
148.27M
166.21%
180.69M
80.22%
142.23M
9.47%
79.09M
13.49%
74.55M
-33.17%
67.88M
-25.40%
78.92M
-16.14%
72.24M
-26.05%
65.69M
20.63%
101.56M
27.61%
105.79M
138.94%
86.15M
总资产
-43.03%
21.02M
-67.77%
20.00M
-81.45%
20.23M
-78.86%
30.17M
-68.54%
36.90M
-62.46%
62.04M
-34.08%
109.10M
-24.41%
142.71M
-52.41%
117.28M
-45.29%
165.27M
-56.03%
165.50M
-48.74%
188.79M
-43.49%
246.44M
-23.96%
302.08M
-19.59%
376.42M
-18.14%
368.32M
-4.53%
436.12M
-24.99%
397.28M
-20.40%
468.13M
10.95%
449.92M
总负债
-19.35%
58.02M
-51.06%
57.31M
-71.54%
58.74M
-71.36%
66.80M
-68.47%
71.94M
-55.57%
117.11M
-22.04%
206.38M
-2.66%
233.25M
-4.53%
228.15M
11.16%
263.58M
5.99%
264.74M
32.24%
239.63M
33.78%
238.99M
37.09%
237.12M
32.50%
249.78M
29.63%
181.20M
42.62%
178.64M
32.44%
172.96M
49.87%
188.51M
170.91%
139.78M
总权益
-5.58%
-37.00M
32.25%
-37.31M
60.42%
-38.50M
59.54%
-36.63M
68.39%
-35.04M
43.98%
-55.07M
1.96%
-97.28M
-78.09%
-90.54M
-1587.36%
-110.87M
-251.34%
-98.31M
-178.36%
-99.23M
-127.17%
-50.84M
-97.11%
7.45M
-71.04%
64.96M
-54.71%
126.64M
-39.67%
187.11M
-22.34%
257.48M
-43.79%
224.32M
-39.52%
279.61M
-12.37%
310.14M
现金流量表
经营净额
54.39%
-3.34M
89.08%
-3.07M
76.72%
-5.70M
-145.35%
-9.79M
31.25%
-7.32M
4.98%
-28.14M
51.45%
-24.47M
92.23%
-3.99M
79.84%
-10.64M
22.94%
-29.61M
11.38%
-50.41M
21.08%
-51.35M
17.46%
-52.80M
54.54%
-38.43M
-65.98%
-56.88M
-10.31%
-65.06M
-3.88%
-63.96M
-28.66%
-84.53M
-731.77%
-34.27M
-11.37%
-58.98M
投资净额
-30.69%
-6.63M
-100.00%
0.00
150.00%
8.44M
85.47%
-2.42M
-170.46%
-5.07M
16.86%
17.20M
-66.05%
3.38M
-123.66%
-16.66M
-85.46%
7.20M
345.00%
14.72M
-80.58%
9.94M
18.01%
70.45M
55.48%
49.48M
-109.98%
-6.01M
310.57%
51.22M
4899.75%
59.70M
-0.20%
31.83M
346.07%
60.22M
34.07%
-24.32M
-84.21%
1.19M
融资净额
-68.47%
4.83M
1280.40%
2.95M
99.09%
-3.00K
-97.07%
1.05M
4823.46%
15.30M
-101.04%
-250.00K
-121.69%
-328.00K
17308.17%
35.79M
-168.79%
-324.00K
10172.77%
24.14M
-95.32%
1.51M
2.80%
-208.00K
-59.29%
471.00K
-98.82%
235.00K
-37.26%
32.29M
-100.45%
-214.00K
-52.72%
1.16M
586.41%
19.85M
-71.21%
51.47M
40.68%
47.14M
常见问题
Atara Biotherapeutics Inc的总收入是多少?
根据Atara Biotherapeutics Inc的FY2025财报,总收入达到了120.77M(同比变化128.94M)。
Atara Biotherapeutics Inc的流动资产是多少?
根据Atara Biotherapeutics Inc的FY2025财报,流动资产为12.21M(同比变化-81.18)。
Atara Biotherapeutics Inc的总资产是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的总资产为20.23M(同比变化-81.45)。
Atara Biotherapeutics Inc的总负债是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的总负债为58.74M(同比变化-71.54)。
Atara Biotherapeutics Inc的总权益是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的总权益为-38.50M(同比变化60.42)。
Atara Biotherapeutics Inc的净营业收入是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的净营业收入为52.57M(同比变化167.11)。
Atara Biotherapeutics Inc的净投资是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的净投资为18.15M(同比变化110.44)。
Atara Biotherapeutics Inc的净融资是多少?
根据Atara Biotherapeutics Inc的FY2025财报,Atara Biotherapeutics Inc的净融资为16.10M(同比变化-72.85)。
Atara Biotherapeutics Inc的每股收益(EPS)是多少?
根据Atara Biotherapeutics Inc的FY2025财报,每股收益(EPS)为2.61(同比变化122.85)。
Atara Biotherapeutics Inc的净利润是多少?
根据Atara Biotherapeutics Inc的FY2025财报,净利润为32.69M(同比变化138.28)。
Atara Biotherapeutics Inc的净利润率是多少?
根据Atara Biotherapeutics Inc的FY2025财报,净利润率为27.07(同比变化140.86)。
Atara Biotherapeutics Inc的毛利率是多少?
根据Atara Biotherapeutics Inc的FY2025财报,毛利率为82.44(同比变化-1.52)。
Atara Biotherapeutics Inc的债务与资产比率是多少?
根据Atara Biotherapeutics Inc的FY2025财报,债务与资产比率为209.65(同比变化454.31)。
Atara Biotherapeutics Inc的资产回报率(ROA)是多少?
根据Atara Biotherapeutics Inc的FY2025财报,资产回报率(ROA)为50.55(同比变化181.27)。
Atara Biotherapeutics Inc的营业利润是多少?
根据Atara Biotherapeutics Inc的FY2025财报,营业利润为52.57M(同比变化167.11)。